Abstract | AIM: To evaluate the efficacies of six derivatives of Compound 2, a novel YycG histidine kinase inhibitor with the thiazolidione core structure in the treatment of medical device-related biofilm infections. METHODS: The minimal inhibitory concentration (MIC) of the derivatives was determined using the macrodilution broth method, and the minimal bactericidal concentration (MBC) was obtained via sub-culturing 100 μL from each negative tube from the MIC assay onto drug-free Mueller-Hinton agar plates. Biofilm-killing effect for immature (6 h-old) biofilms was examined using a semiquantitative plate assay, and the effect on mature (24 h-old) biofilms was observed under a confocal laser scanning microscope (CLSM). RESULTS: The derivatives potently suppressed the growth of Staphylococcus epidermidis. The MIC values of the derivatives H2-10, H2-12, H2-20, H2-29, H2-27, and H2-28 on S epidermidis ATCC 35984 were 24.3, 6.5, 6.2, 3.3, 3.1, and 1.5 μg/mL, respectively. The MBC values of these derivatives were 48.6, 52.2, 12.4, 52.6, 12.4, and 6.2 μg/mL, respectively. The derivatives killed all bacteria in immature (6 h-old) biofilms and eliminated the biofilm proliferation. The derivatives also displayed strong bactericidal activities toward cells in mature (24 h-old) biofilms, whereas they showed low cytotoxicity and hemolytic activity toward Vero cells and human erythrocytes. CONCLUSION: The bactericidal and biofilm-killing activities of the new anti-YycG compounds were significantly better than the parent Compound 2.
|
Authors | Ren-zheng Huang, Li-kang Zheng, Hua-yong Liu, Bin Pan, Jian Hu, Tao Zhu, Wei Wang, Dan-bin Jiang, Yang Wu, You-cong Wu, Shi-qing Han, Di Qu |
Journal | Acta pharmacologica Sinica
(Acta Pharmacol Sin)
Vol. 33
Issue 3
Pg. 418-25
(Mar 2012)
ISSN: 1745-7254 [Electronic] United States |
PMID | 22231397
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Protein Kinase Inhibitors
- Thiazoles
- Protein Kinases
- Histidine Kinase
- YycG protein, Staphylococcus epidermidis
|
Topics |
- Anti-Bacterial Agents
(pharmacology)
- Biofilms
(drug effects)
- Histidine Kinase
- Plankton
(drug effects)
- Protein Kinase Inhibitors
(pharmacology)
- Protein Kinases
(metabolism)
- Staphylococcal Infections
(drug therapy, metabolism)
- Staphylococcus epidermidis
(drug effects, metabolism)
- Thiazoles
(pharmacology)
|